Key result
Type 2 diabetic patients demonstrated increased sympathetic and decreased parasympathetic cardiac activity compared to controls, regardless of the presence of autonomic neuropathy.
Why the study?
Does spectral analysis of heart rate variability by wavelet transform reveal incipient cardiovascular autonomic imbalance in Type 2 diabetic patients?
Observational (n=130)
Does spectral analysis of heart rate variability by wavelet transform reveal incipient cardiovascular autonomic imbalance in Type 2 diabetic patients?
Wavelet analysis of heart rate variability reveals incipient cardiovascular autonomic imbalance (increased sympathetic and decreased parasympathetic activity) in Type 2 diabetic patients, even prior to the development of clinical autonomic neuropathy.
Supports wavelet HRV analysis for detecting early autonomic imbalance in T2DM; hypothesis-generating for prognostic value and intervention trials.
AIM: Incipient cardiovascular autonomic imbalance is not readily diagnosed by conventional methods. Spectral analysis of heart rate variability (HRV) by wavelet transform (WT) was used to measure cardiovascular autonomic function in patients with Type 2 diabetes. METHODS: Thirty-two diabetic patients without (D), 26 with cardiovascular autonomic neuropathy (DAN) and 72 control subjects (C) participated. A 30-min HRV time series was analysed by wavelet transformation and four characteristic frequency intervals were defined: I (0.0095-0.021 Hz), II (0.021-0.052 Hz), III (0.052-0.145 Hz) and IV (0.145-0.6 Hz). RESULTS: When compared with C, in both D and DAN the normalized power and amplitude of interval II were increased and of interval IV decreased, resulting in a significantly higher II/IV ratio. Furthermore, in DAN the normalized power and amplitude of interval I were increased and of interval III decreased when compared with the D and C groups. The diabetic patients were divided in two equal subgroups according to HbA(1c) < 8.0% and >or= 8.0%. In the subgroup with HbA(1c) >or= 8.0%, normalized power in interval II was significantly higher and in interval IV significantly lower than in the subgroup with HbA(1c) < 8.0%. In D, but not in DAN patients prescribed ACE inhibitors, the absolute amplitude and power of oscillations were significantly higher than in patients not taking ACE inhibitor therapy. CONCLUSIONS: Patients with diabetes have increased sympathetic and decreased parasympathetic cardiac activity regardless of the presence of autonomic neuropathy. Glycaemic control and treatment with ACE inhibitors may favourably influence HRV in diabetic patients without autonomic neuropathy.
No takes yet. Share an insight, caveat, or question.
Urbančič‐Rovan et al. (2007) conducted an observational in Type 2 diabetes (n=130). Type 2 diabetes vs. Control subjects was evaluated on Cardiovascular autonomic function measured by spectral analysis of heart rate variability (HRV) using wavelet transform. Type 2 diabetic patients demonstrated increased sympathetic and decreased parasympathetic cardiac activity compared to controls, regardless of the presence of autonomic neuropathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: